Company · Ownership research

KalVista Pharmaceuticals, Inc. KALV

CIK 0001348911

Form 4 transactions dated Nov 1, 2023 to Nov 11, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Jun 11, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $19.44M
Sold: $16.29M

Nov 1, 2023 – Jun 11, 2026
Available records · partial months are marked ·

2023, from Nov 1, 20239 of 9 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 29, 2023	Koh Bong Y · Shah Nimish P · Venrock Healthcare Capital Partners III, L.P. · VHCP Management III, LLC · VHCP Co-Investment Holdings III, LLC · Venrock Healthcare Capital Partners EG, L.P. · VHCP Management EG, LLC 10% owner	Purchase	$75.10K 6,013 shares bought	Unavailable Indirect holding	▾
Dec 28, 2023	Koh Bong Y · Shah Nimish P · Venrock Healthcare Capital Partners III, L.P. · VHCP Management III, LLC · VHCP Co-Investment Holdings III, LLC · Venrock Healthcare Capital Partners EG, L.P. · VHCP Management EG, LLC 10% owner	Purchase	$5.89M 471,490 shares bought	Unavailable Indirect holding	▾
Dec 27, 2023	Koh Bong Y · Shah Nimish P · Venrock Healthcare Capital Partners III, L.P. · VHCP Management III, LLC · VHCP Co-Investment Holdings III, LLC · Venrock Healthcare Capital Partners EG, L.P. · VHCP Management EG, LLC 10% owner	Purchase	$496.92K 41,514 shares bought	Unavailable Indirect holding	▾
Dec 27, 2023	Crockett Thomas Andrew CEO · Director	Sale10b5-1 footnote	$360.45K 30,000 shares sold	19.04% sold Direct holding	▾
Nov 20, 2023	Audhya Paul K. Chief Medical Officer	Sale	$65.71K 7,985 shares sold	17.92% sold Direct holding	▾
Nov 20, 2023	Feener Edward P. Chief Scientific Officer	Sale	$40.80K 4,958 shares sold	5.85% sold Direct holding	▾
Nov 20, 2023	Yea Christopher Chief Development Officer	Sale	$58.54K 7,113 shares sold	13.38% sold Direct holding	▾
Nov 20, 2023	Palleiko Benjamin L President, CFO, CBO & Sec'y	Sale	$107.05K 13,008 shares sold	10.37% sold Direct holding	▾
Nov 20, 2023	Crockett Thomas Andrew CEO · Director	Sale	$121.85K 14,807 shares sold	8.59% sold Direct holding	▾

Showing 9 / 9 record groups in 2023. The complete set is available through the API.

KalVista Pharmaceuticals, Inc. · KALV

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 9 of 9 purchase / sale groups and 20 of 20 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"KALV","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.